Cipla Share Price, Stock Analysis & Company Profile
Welcome to the comprehensive stock analysis page for Cipla Ltd. Here, you can track the Cipla share price, analyse the company's financial health, and stay updated with the latest market news. Whether you are tracking the Cipla share price today for long-term investment or monitoring your portfolio, this page provides all the essential tools and reports for a detailed stock analysis.
About Cipla Ltd.
Cipla Ltd., established in 1935, is one of India’s most prominent and globally respected pharmaceutical companies. With a rich legacy spanning over eight decades, the company has transformed from a domestic manufacturer into a global healthcare leader. Cipla is renowned for its commitment to making medicines affordable and accessible, notably revolutionising HIV/AIDS treatment with its dollar-a-day "Triomune" therapy.
Headquartered in Mumbai, Cipla has a vast manufacturing footprint with 47 state-of-the-art facilities across the world. The company produces over 1,500 products in more than 50 dosage forms, catering to 80+ markets. It holds a leadership position in the respiratory segment and has a significant presence in urology, cardiology, and anti-infectives.
Business Model
Cipla operates on a diversified business model that balances stability with high-growth opportunities across geographies:
-
One-India Strategy: India remains the company’s largest market, contributing significantly to its revenue through a mix of prescription drugs, branded generics, and its consumer healthcare business (Cipla Health). It leads in key therapeutic areas like respiratory and urology.
-
North America Business: This vertical focuses on complex generics and value-added products, particularly in the respiratory and peptide segments. Products like Albuterol and Lanreotide have been key growth drivers in the US market.
-
South Africa (SAGA): Cipla is one of the largest pharmaceutical players in South Africa, operating under the "One Africa" strategy. It focuses on private and tender markets, ensuring a steady stream of revenue from the continent.
-
API and Emerging Markets: The company also manufactures Active Pharmaceutical Ingredients (APIs) for its own use and external sale, while expanding its footprint in emerging markets across Europe, Australia, and Latin America.
Listing Information
Cipla Ltd. is a blue-chip stock listed on India’s primary stock exchanges. Below are the static details regarding its listing, which serve as a permanent reference for investors.
-
Listing Year: 1995 (Listed on NSE/BSE)
-
Face Value: Rs 2 per share
-
ISIN: INE059A01026
-
Listing Exchanges: BSE and NSE
-
BSE Scrip Code: 500087
-
NSE Symbol: CIPLA
Investor Resources Available on This Page
We believe in empowering retail investors with professional-grade data. On this page, you can access a wealth of information to conduct your own Cipla stock analysis:
-
Interactive Price Chart: Analyse historical price movements and trends (data delayed by 15 minutes).
-
Company Ratios: Access a detailed table of key financial metrics such as PE ratio, ROE, and ROCE to evaluate valuation and efficiency.
-
Quarterly Results & Balance Sheet: Review the company’s latest quarterly earnings, profit and loss statements, and balance sheets to assess financial stability.
-
Cash Flow Analysis: Understand the company's liquidity position through detailed cash flow statements.
-
Shareholding Pattern: Check the latest ownership data, including promoter holdings and participation by FIIs and DIIs.
-
Annual Reports: Download official Annual Reports and investor presentations directly from the "Reports Section" on this page.
Frequently Asked Questions (FAQs)
Q1. What is the Cipla share price today?
The share price displayed at the top of this page reflects the latest trading value on the NSE and BSE. Please note that the price chart data is delayed by 15 minutes.
Q2. What are Cipla's main therapeutic areas?
Cipla is a global leader in respiratory medicines. It also has a strong portfolio in anti-retrovirals (HIV/AIDS), urology, cardiology, anti-infectives, and central nervous system (CNS) therapies.
Q3. Is Cipla a debt-free company?
Cipla maintains a very strong balance sheet with negligible debt. You can check the exact debt figures in the "Balance Sheet" or "Ratios" section on this page to confirm its current status.
Q4. Does Cipla pay dividends?
Yes, Cipla has a consistent track record of paying dividends to its shareholders. You can view the dividend yield and payout history in the "Corporate Actions" section.
Q5. Where is Cipla listed?
Cipla shares are traded on both the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE).
Q6. How can I download the Cipla Annual Report?
You can easily download the latest Annual Report and investor presentations from the "Documents" or "Reports Section" available on this page.
Q7. What is the face value of Cipla shares?
The face value of each equity share is Rs 2. This has been the face value since the company's stock split in the past.